1. Home
  2. CDT vs SIF Comparison

CDT vs SIF Comparison

Compare CDT & SIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • SIF
  • Stock Information
  • Founded
  • CDT 2019
  • SIF 1913
  • Country
  • CDT United States
  • SIF United States
  • Employees
  • CDT N/A
  • SIF N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • SIF Office Equipment/Supplies/Services
  • Sector
  • CDT Health Care
  • SIF Industrials
  • Exchange
  • CDT Nasdaq
  • SIF Nasdaq
  • Market Cap
  • CDT 11.9M
  • SIF 29.4M
  • IPO Year
  • CDT N/A
  • SIF N/A
  • Fundamental
  • Price
  • CDT $0.10
  • SIF $4.34
  • Analyst Decision
  • CDT
  • SIF
  • Analyst Count
  • CDT 0
  • SIF 0
  • Target Price
  • CDT N/A
  • SIF N/A
  • AVG Volume (30 Days)
  • CDT 20.6M
  • SIF 17.0K
  • Earning Date
  • CDT 11-18-2024
  • SIF 08-12-2024
  • Dividend Yield
  • CDT N/A
  • SIF N/A
  • EPS Growth
  • CDT N/A
  • SIF N/A
  • EPS
  • CDT N/A
  • SIF N/A
  • Revenue
  • CDT N/A
  • SIF $101,482,000.00
  • Revenue This Year
  • CDT N/A
  • SIF N/A
  • Revenue Next Year
  • CDT N/A
  • SIF N/A
  • P/E Ratio
  • CDT N/A
  • SIF N/A
  • Revenue Growth
  • CDT N/A
  • SIF 25.24
  • 52 Week Low
  • CDT $0.10
  • SIF $2.87
  • 52 Week High
  • CDT $7.83
  • SIF $5.96
  • Technical
  • Relative Strength Index (RSI)
  • CDT 38.05
  • SIF 47.49
  • Support Level
  • CDT $0.10
  • SIF $4.10
  • Resistance Level
  • CDT $0.11
  • SIF $4.50
  • Average True Range (ATR)
  • CDT 0.01
  • SIF 0.28
  • MACD
  • CDT 0.00
  • SIF -0.03
  • Stochastic Oscillator
  • CDT 10.48
  • SIF 39.76

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About SIF SIFCO Industries Inc.

SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.

Share on Social Networks: